FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026743531> ?p ?o ?g. }

• W3026743531 endingPage "1264" @default.
• W3026743531 startingPage "1253" @default.
• W3026743531 abstract "Abstract Toxoplasmosis is highly endemic worldwide. In Brazil, depending on the geographical region and socioeconomic status, 40–70% of individuals become seropositive at some point in their lives. A significant proportion of Toxoplasma gondii-chronically infected individuals who are otherwise immunocompetent develop recurrent ocular lesions. The inflammatory/immune mechanisms involved in development of ocular lesion are still unknown and, despite previous investigation, there are no reliable immune biomarkers to predict/follow disease outcome. To better understand the impact of the immune response on parasite control and immunopathology of ocular toxoplasmosis, and to provide insights on putative biomarkers for disease monitoring, we assessed the production of a large panel of circulating immune mediators in a longitudinal study of patients with postnatally acquired toxoplasmosis stratified by the presence of ocular involvement, both at the early acute stage and 6 months later during chronic infection, correlating them with presence of ocular involvement. We found that T. gondii-infected patients, especially during the acute stage of the disease, display high levels of chemokines, cytokines, and growth factors involved in the activation, proliferation, and migration of inflammatory cells to injured tissues. In particular, major increases were found in the IFN-induced chemokines CXCL9 and CXCL10 in T. gondii-infected patients regardless of disease stage or clinical manifestations. Moreover, a specific subgroup of circulating cytokines and chemokines including GM-CSF, CCL25, CCL11, CXCL12, CXCL13, and CCL2 was identified as potential biomarkers that accurately distinguish different stages of infection and predict the occurrence of ocular toxoplasmosis. In addition to serving as predictors of disease development, these host inflammatory molecules may offer promise as candidate targets for therapeutic intervention." @default.
• W3026743531 created "2020-05-29" @default.
• W3026743531 creator A5002478338 @default.
• W3026743531 creator A5008274219 @default.
• W3026743531 creator A5014943780 @default.
• W3026743531 creator A5016487212 @default.
• W3026743531 creator A5017523406 @default.
• W3026743531 creator A5018625719 @default.
• W3026743531 creator A5022976564 @default.
• W3026743531 creator A5027499865 @default.
• W3026743531 creator A5070987886 @default.
• W3026743531 creator A5073562393 @default.
• W3026743531 creator A5074181163 @default.
• W3026743531 creator A5074531696 @default.
• W3026743531 creator A5084364506 @default.
• W3026743531 creator A5087159302 @default.
• W3026743531 date "2020-05-18" @default.
• W3026743531 modified "2023-10-14" @default.
• W3026743531 title "Circulating inflammatory mediators as biomarkers of ocular toxoplasmosis in acute and in chronic infection" @default.
• W3026743531 cites W1496007453 @default.
• W3026743531 cites W1537640495 @default.
• W3026743531 cites W1545910465 @default.
• W3026743531 cites W1970279912 @default.
• W3026743531 cites W1982293312 @default.
• W3026743531 cites W1984064011 @default.
• W3026743531 cites W1997491414 @default.
• W3026743531 cites W1997794442 @default.
• W3026743531 cites W1998047654 @default.
• W3026743531 cites W1998998882 @default.
• W3026743531 cites W2010708956 @default.
• W3026743531 cites W2023245937 @default.
• W3026743531 cites W2037751912 @default.
• W3026743531 cites W2049759090 @default.
• W3026743531 cites W2052225967 @default.
• W3026743531 cites W2053583874 @default.
• W3026743531 cites W2063965112 @default.
• W3026743531 cites W2067873629 @default.
• W3026743531 cites W2071834286 @default.
• W3026743531 cites W2084241860 @default.
• W3026743531 cites W2097659338 @default.
• W3026743531 cites W2101594125 @default.
• W3026743531 cites W2103574748 @default.
• W3026743531 cites W2108640938 @default.
• W3026743531 cites W2111180084 @default.
• W3026743531 cites W2111253543 @default.
• W3026743531 cites W2114123652 @default.
• W3026743531 cites W2114962227 @default.
• W3026743531 cites W2129071472 @default.
• W3026743531 cites W2152283755 @default.
• W3026743531 cites W2160927547 @default.
• W3026743531 cites W2171545494 @default.
• W3026743531 cites W2209894880 @default.
• W3026743531 cites W2291980640 @default.
• W3026743531 cites W2333852990 @default.
• W3026743531 cites W2593337780 @default.
• W3026743531 cites W2955349593 @default.
• W3026743531 doi "https://doi.org/10.1002/jlb.4ma0420-702r" @default.
• W3026743531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32421913" @default.
• W3026743531 hasPublicationYear "2020" @default.
• W3026743531 type Work @default.
• W3026743531 sameAs 3026743531 @default.
• W3026743531 citedByCount "11" @default.
• W3026743531 countsByYear W30267435312021 @default.
• W3026743531 countsByYear W30267435312022 @default.
• W3026743531 countsByYear W30267435312023 @default.
• W3026743531 crossrefType "journal-article" @default.
• W3026743531 hasAuthorship W3026743531A5002478338 @default.
• W3026743531 hasAuthorship W3026743531A5008274219 @default.
• W3026743531 hasAuthorship W3026743531A5014943780 @default.
• W3026743531 hasAuthorship W3026743531A5016487212 @default.
• W3026743531 hasAuthorship W3026743531A5017523406 @default.
• W3026743531 hasAuthorship W3026743531A5018625719 @default.
• W3026743531 hasAuthorship W3026743531A5022976564 @default.
• W3026743531 hasAuthorship W3026743531A5027499865 @default.
• W3026743531 hasAuthorship W3026743531A5070987886 @default.
• W3026743531 hasAuthorship W3026743531A5073562393 @default.
• W3026743531 hasAuthorship W3026743531A5074181163 @default.
• W3026743531 hasAuthorship W3026743531A5074531696 @default.
• W3026743531 hasAuthorship W3026743531A5084364506 @default.
• W3026743531 hasAuthorship W3026743531A5087159302 @default.
• W3026743531 hasConcept C13373296 @default.
• W3026743531 hasConcept C142724271 @default.
• W3026743531 hasConcept C159654299 @default.
• W3026743531 hasConcept C17502307 @default.
• W3026743531 hasConcept C203014093 @default.
• W3026743531 hasConcept C2778062946 @default.
• W3026743531 hasConcept C2778128430 @default.
• W3026743531 hasConcept C2779134260 @default.
• W3026743531 hasConcept C5858377 @default.
• W3026743531 hasConcept C71924100 @default.
• W3026743531 hasConcept C86803240 @default.
• W3026743531 hasConcept C8891405 @default.
• W3026743531 hasConceptScore W3026743531C13373296 @default.
• W3026743531 hasConceptScore W3026743531C142724271 @default.
• W3026743531 hasConceptScore W3026743531C159654299 @default.
• W3026743531 hasConceptScore W3026743531C17502307 @default.
• W3026743531 hasConceptScore W3026743531C203014093 @default.
• W3026743531 hasConceptScore W3026743531C2778062946 @default.

• next